KROS — KEROS THERAPEUTICS INC

Ownership history in Covestor Ltd  ·  4 quarters on record

This page tracks every 13F SEC filing in which Covestor Ltd reported a position in KEROS THERAPEUTICS INC (KROS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.12% (2025 Q1)
Avg. % of fund
0.06%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 3,507 -5,842 -62.5% 0.03% $55K $15.82
2025 Q2 REDUCED 9,349 -7,712 -45.2% 0.07% $125K $13.35
2025 Q1 ADDED 17,061 +15,779 +1230.8% 0.12% $174K $10.19
2024 Q4 INITIATED 1,282 — — 0.01% $20K $15.83
% of Fund (quarterly)    KROS price (monthly, adj. close)

Other funds also holding KROS

As of 2025 Q4 — sorted by position size

Rangeley Capital, LLC 1.64% Madison Avenue Partners, LP 3Y 0.72% ORBIMED ADVISORS LLC 3Y 7Y 0.33% Nantahala Capital Management, LLC 3Y 7Y 0.24% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.21% Quantedge Capital Pte Ltd 3Y 0.19% OXFORD ASSET MANAGEMENT LLP 3Y 7Y 0.18% EJF Capital LP 3Y 7Y 0.17% Nantahala Capital Management, LLC 3Y 7Y 0.17% PDT Partners, LLC 3Y 7Y 0.15%
← Back to Covestor Ltd Holdings